000917327 001__ 917327
000917327 005__ 20230224084259.0
000917327 0247_ $$2doi$$a10.1016/j.neuint.2022.105422
000917327 0247_ $$2ISSN$$a0197-0186
000917327 0247_ $$2ISSN$$a1872-9754
000917327 0247_ $$2pmid$$a36252819
000917327 0247_ $$2WOS$$aWOS:000880099200004
000917327 037__ $$aFZJ-2023-00555
000917327 082__ $$a540
000917327 1001_ $$0P:(DE-Juel1)165152$$aSevenich, Marc$$b0$$ufzj
000917327 245__ $$aDevelopment of an α-synuclein fibril and oligomer specific tracer for diagnosis of Parkinson's disease, dementia with Lewy bodies and multiple system atrophy
000917327 260__ $$aAmsterdam [u.a.]$$bElsevier Science$$c2022
000917327 3367_ $$2DRIVER$$aarticle
000917327 3367_ $$2DataCite$$aOutput Types/Journal article
000917327 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1673610662_4157
000917327 3367_ $$2BibTeX$$aARTICLE
000917327 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000917327 3367_ $$00$$2EndNote$$aJournal Article
000917327 520__ $$aThe development of specific disease-associated PET tracers is one of the major challenges, the realization of which in neurodegenerative diseases would enable not only the efficiency of diagnosis but also support the development of disease-modifying therapeutics. Parkinson's disease (PD) is the most common neurodegenerative movement disorder and is characterized by neuronal fibrillary inclusions composed of aggregated α-synuclein (α-syn). However, these deposits are not only found in PD, but also in other related diseases such as multiple system atrophy (MSA) and dementia with Lewy bodies (DLB), which are grouped under the term synucleinopathies. In this study, we used NGS-guided phage display selection to identify short peptides that bind aggregated α-syn. By surface plasmon resonance (SPR)-based affinity screening, we identified the peptide SVLfib-5 that recognizes aggregated α-syn with high complex stability and sequence specificity. Further analysis SPR showed that SVLfib-5 is not only specific for aggregated α-syn, but in particular recognizes fibrillary and oligomeric structures. Moreover, fluorescence microscopy of human brain tissue sections from PD, MSA, and DLB patients with SVLfib-5 allowed specific recognition of α-syn and a clear discrimination between diseased and non-diseased samples. These findings provide the basis for the further development of an α-syn PET tracer for early diagnosis and monitoring of disease progression and therapy progress.
000917327 536__ $$0G:(DE-HGF)POF4-5244$$a5244 - Information Processing in Neuronal Networks (POF4-524)$$cPOF4-524$$fPOF IV$$x0
000917327 536__ $$0G:(GEPRIS)267205415$$aSFB 1208 B02 - Identität und Dynamik von Membransystemen - von Molekülen bis zu zellulären Funktionen (267205415)$$c267205415$$x1
000917327 588__ $$aDataset connected to CrossRef, Journals: juser.fz-juelich.de
000917327 7001_ $$0P:(DE-Juel1)164541$$aHonold, Dominik$$b1$$ufzj
000917327 7001_ $$0P:(DE-Juel1)144347$$aWilluweit, Antje$$b2$$ufzj
000917327 7001_ $$0P:(DE-Juel1)159137$$aKutzsche, Janine$$b3$$ufzj
000917327 7001_ $$0P:(DE-Juel1)132012$$aMohrlüder, Jeannine$$b4$$ufzj
000917327 7001_ $$0P:(DE-Juel1)132029$$aWillbold, Dieter$$b5$$eCorresponding author$$ufzj
000917327 773__ $$0PERI:(DE-600)1500654-2$$a10.1016/j.neuint.2022.105422$$gVol. 161, p. 105422 -$$p105422 -$$tNeurochemistry international$$v161$$x0197-0186$$y2022
000917327 8564_ $$uhttps://juser.fz-juelich.de/record/917327/files/1-s2.0-S0197018622001474.pdf
000917327 909CO $$ooai:juser.fz-juelich.de:917327$$pVDB
000917327 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)165152$$aForschungszentrum Jülich$$b0$$kFZJ
000917327 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)164541$$aForschungszentrum Jülich$$b1$$kFZJ
000917327 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)144347$$aForschungszentrum Jülich$$b2$$kFZJ
000917327 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)159137$$aForschungszentrum Jülich$$b3$$kFZJ
000917327 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)132012$$aForschungszentrum Jülich$$b4$$kFZJ
000917327 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)132029$$aForschungszentrum Jülich$$b5$$kFZJ
000917327 9131_ $$0G:(DE-HGF)POF4-524$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5244$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vMolecular and Cellular Information Processing$$x0
000917327 9141_ $$y2022
000917327 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2022-11-25$$wger
000917327 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bNEUROCHEM INT : 2021$$d2022-11-25
000917327 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-25
000917327 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-25
000917327 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2022-11-25
000917327 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2022-11-25
000917327 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-25
000917327 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2022-11-25
000917327 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2022-11-25
000917327 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-25
000917327 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2022-11-25
000917327 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2022-11-25
000917327 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2022-11-25
000917327 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2022-11-25
000917327 920__ $$lyes
000917327 9201_ $$0I:(DE-Juel1)IBI-7-20200312$$kIBI-7$$lStrukturbiochemie$$x0
000917327 980__ $$ajournal
000917327 980__ $$aVDB
000917327 980__ $$aI:(DE-Juel1)IBI-7-20200312
000917327 980__ $$aUNRESTRICTED